Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Perspective Therapeutics, Inc.ISR · Entity 694 | Principal Fin & Acct Officer | June 15, 2017 | July 06, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Perspective Therapeutics, Inc.
Report date June 15, 2017 · Filed July 06, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.53 · Expires 2025-03-10 | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-15 · Disposition to issuer · Disposed 15,000 · Balance 0 F1: The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2026-06-21 | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-06-15 · Disposition to issuer · Disposed 25,000 · Balance 0 F1: The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options. |
Filing footnotes · ownership attribution and instrument terms
F1: The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2017 Filed Jul 6, 2017 19:50 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Disposition to issuerStock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001642247-17-000018 · primary_doc.xml · derivative · entry 2 Branson Matthew · CIK 0001696098 · Principal Fin & Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-06-21 F1 · security: The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options. F1 · derivative.exercise_date: The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options. Read SEC document |
| June 15, 2017 Filed Jul 6, 2017 19:50 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Disposition to issuerStock Options (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001642247-17-000018 · primary_doc.xml · derivative · entry 1 Branson Matthew · CIK 0001696098 · Principal Fin & Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-03-10 F1 · security: The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options. F1 · derivative.exercise_date: The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.